⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14950040 | 0.91 | — | — | |
| SCHEMBL4082947 | 0.89 | — | — | |
| SCHEMBL1255188 | 0.87 | MEN1 (0.59) | — | |
| SCHEMBL19288192 | 0.81 | — | — | |
| SCHEMBL23388213 | 0.80 | — | — | |
| SCHEMBL15380920 | 0.80 | — | — | |
| SCHEMBL4085280 | 0.79 | MEN1 (0.62) | — | |
| Oseltamivir Carboxylate SCHEMBL1977050 | 0.78 | — | — | |
| Oseltamivir Carboxylate SCHEMBL20607528 | 0.78 | — | — | |
| Oseltamivir Carboxylate SCHEMBL14080012 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021099419-A1 | METHOD FOR PRODUCING REASSORTANT INFLUENZA VIRUSES | Seqirus UK Limited (GB) | 2021-05-27 | — | — | WO | disclosed |
| EP-3197487-A1 | VACCINATION OF IMMUNOCOMPROMISED SUBJECTS | Seqirus UK Limited (GB) | 2017-08-02 | — | — | EP | disclosed |
| EP-3004332-A2 | INFLUENZA VIRUS REASSORTMENT | Novartis AG (CH) | 2016-04-13 | — | — | EP | disclosed |
| WO-2016046799-A1 | VACCINATION OF IMMUNOCOMPROMISED SUBJECTS | Seqirus UK Limited (GB) | 2016-03-31 | — | — | WO | disclosed |
| EP-2968512-A2 | INFLUENZA B VIRUS REASSORTMENT | Novartis AG (CH) | 2016-01-20 | — | — | EP | disclosed |
| EP-2948175-A1 | INFLUENZA VIRUS REASSORTMENT | Novartis AG (CH) | 2015-12-02 | — | — | EP | disclosed |
| EP-2925356-A2 | REASSORTANT INFLUENZA A VIREN | Novartis AG (CH) | 2015-10-07 | — | — | EP | disclosed |
| US-20150246110-A1 | ADJUVANTED INFLUENZA VACCINES INCLUDING CYTOKINE-INDUCING AGENTS | NOVARTIS AG (CH) | 2015-09-03 | — | — | US | disclosed |
| EP-2906231-A2 | INFLUENZA VIRUS AND TYPE 1 DIABETES | Ospedale San Raffaele S.r.l. (IT) | 2015-08-19 | — | — | EP | disclosed |
| EP-2396030-B1 | INFLUENZA VACCINE REGIMENS FOR PANDEMIC-ASSOCIATED STRAINS | NOVARTIS AG (CH) | 2015-08-12 | — | — | EP | disclosed |
| WO-2007085969-A2 | INFLUENZA VACCINES CONTAINING HEMAGGLUTININ AND MATRIX PROTEINS | NOVARTIS VACCINES AND DIAGNOSTICS GMBH & CO KG (DE) | 2007-08-02 | — | — | WO | disclosed |
| WO-2007052056-A1 | ADJUVANTED INFLUENZA VACCINES INCLUDING CYTOKINE-INDUCING AGENTS | NOVARTIS VACCINES AND DIAGNOSTICS SRL (IT) | 2007-05-10 | — | — | WO | disclosed |
| WO-2007052055-A1 | ADJUVANTED VACCINES WITH NON-VIRION ANTIGENS PREPARED FROM INFLUENZA VIRUSES GROWN IN CELL CULTURE | NOVARTIS VACCINES AND DIAGNOSTICS SRL (IT) | 2007-05-10 | — | — | WO | disclosed |
| WO-2007052163-A2 | CELL-DERIVED VIRAL VACCINES WITH LOW LEVELS OF RESIDUAL CELL DNA BY BETA-PROPIOLACTONE TREATMENT | NOVARTIS VACCINES AND DIAGNOSTICS GMBH & CO KG (DE) | 2007-05-10 | — | — | WO | disclosed |
| WO-2007052060-A1 | INFLUENZA VACCINES EXTEMPORANEOUSLY ADSORBED TO ALUMINIUM ADJUVANTS | NOVARTIS VACCINES AND DIAGNOSTICS SRL (IT) | 2007-05-10 | — | — | WO | disclosed |
| WO-2007052057-A2 | ADMINSTRATION ROUTES FOR PRIMING/BOOSTING WITH INFLUENZA VACCINES | NOVARTIS VACCINES AND DIAGNOSTICS SRL (IT) | 2007-05-10 | — | — | WO | disclosed |
| WO-2007052155-A2 | INFLUENZA VACCINE WITH REDUCED AMOUNT OF OIL-IN-WATER EMULSION AS ADJUVANT | NOVARTIS VACCINES AND DIAGNOSTICS SRL (IT) | 2007-05-10 | — | — | WO | disclosed |
| WO-2007052061-A2 | EMULSIONS WITH FREE AQUEOUS-PHASE SURFACTANT AS ADJUVANTS FOR SPLIT INFLUENZA VACCINES | NOVARTIS VACCINES AND DIAGNOSTICS SRL (IT) | 2007-05-10 | — | — | WO | disclosed |
| WO-2007052058-A1 | INFLUENZA VACCINES INCLUDING COMBINATIONS OF PARTICULATE ADJUVANTS AND IMMUNOPOTENTIATORS | NOVARTIS VACCINES AND DIAGNOSTICS SRL (IT) | 2007-05-10 | — | — | WO | disclosed |
| WO-2007052059-A2 | CHANGING TH1/TH2 BALANCE IN SPLIT INFLUENZA VACCINES WITH ADJUVANTS | NOVARTIS VACCINES AND DIAGNOSTICS SRL (IT) | 2007-05-10 | — | — | WO | disclosed |